Cargando…
Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line
BACKGROUND: Reprimo (RPRM), a highly glycosylated protein, is a new downstream effector of p53-induced cell cycle arrest at the G2/M checkpoint, and a putative tumor suppressor gene frequently silenced via methylation of its promoter region in several malignances. The aim of this study was to charac...
Autores principales: | Buchegger, Kurt, Ili, Carmen, Riquelme, Ismael, Letelier, Pablo, Corvalán, Alejandro H., Brebi, Priscilla, Huang, Tim Hui-Ming, Roa, Juan Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722741/ https://www.ncbi.nlm.nih.gov/pubmed/26796959 http://dx.doi.org/10.1186/s40659-016-0066-7 |
Ejemplares similares
-
Reprimo, a Potential p53-Dependent Tumor Suppressor Gene, Is Frequently Hypermethylated in Estrogen Receptor α-Positive Breast Cancer
por: Buchegger, Kurt, et al.
Publicado: (2017) -
A reliable Epstein-Barr Virus classification based on phylogenomic and population analyses
por: Zanella, Louise, et al.
Publicado: (2019) -
Potential Effects of Chrysin on MDA-MB-231 Cells
por: Hong, Teh Ban, et al.
Publicado: (2010) -
The Emerging Role of PIWI-Interacting RNAs (piRNAs) in Gastrointestinal Cancers: An Updated Perspective
por: Riquelme, Ismael, et al.
Publicado: (2021) -
Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell line
por: Viscarra, Tamara, et al.
Publicado: (2019)